[
    [
        {
            "time": "2021-07-22",
            "original_text": "乐普医疗：公司暂未涉及可吸收的心脏瓣膜",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "心脏瓣膜",
                    "可吸收"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "心血管"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "乐普医疗：公司暂未涉及可吸收的心脏瓣膜",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-07-22",
            "original_text": "乐普医疗：通过控股博思美进入口腔正畸领域",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "博思美",
                    "口腔正畸"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "口腔健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "乐普医疗：通过控股博思美进入口腔正畸领域",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-22",
            "original_text": "乐普医疗：为国际事业部定下“5年10倍”的计划，定下“国际事业部营业收入提升到30%”的目标，在2020年已见效",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "国际事业部",
                    "营收增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "国际市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：为国际事业部定下“5年10倍”的计划，定下“国际事业部营业收入提升到30%”的目标，在2020年已见效",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-07-22",
            "original_text": "乐普医疗：2021半年度介入无植入产品实现销售收入 3.64亿元，较去年同期增长1951.6%，二季度较一季度环比增幅 75.6%",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "介入无植入",
                    "销售收入",
                    "增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "心血管"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：2021半年度介入无植入产品实现销售收入 3.64亿元，较去年同期增长1951.6%，二季度较一季度环比增幅 75.6%",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-22",
            "original_text": "乐普医疗：一季度营业收入为274,929.11万元，其中新冠疫情期间体外诊断产品业务收入为60,655.04万元",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "营业收入",
                    "新冠检测",
                    "体外诊断"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "诊断"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：一季度营业收入为274,929.11万元，其中新冠疫情期间体外诊断产品业务收入为60,655.04万元",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]